View Press Releases
-
Kalderos Attracts Two Recognized Industry Leaders to Board of Directors
New Kalderos board members bring broad legal, regulatory, and corporate leadership experience across healthcare, biopharmaceutical, and pharmacy industries.
Feb 26, 2024
-
Optibrium Launches a Metabolism Prediction Software Platform Tailored to DMPK Scientists
Optibrium has launched Semeta™, a metabolism prediction platform tailored specifically for drug metabolism and pharmacokinetics (DMPK) scientists. Fundamental to improving a drug’s chance of clinical success, Semeta allows the accurate prediction of Phase I and II metabolic routes, sites, products and liabilities in early drug discovery, with superior precision to comparable software.
Feb 26, 2024
-
Avalon Saves Clients Millions, Sees Record Growth in 2023
Also, in 2023, Avalon launched Precision Genetic Testing Management (PGTM), the next evolution of its genetic test management solution.
Feb 26, 2024
-
Pioneering Human Whole Genome PacBio SMRT Sequencing with CD Genomics
-
Automation and Robotics Reshaping the Future of Care
The healthcare industry is embracing automation and robotics, offering exciting changes. Automation empowers healthcare providers by streamlining tasks and allowing for personalized medicine.
Feb 27, 2024
-
Driving Genomic Research Forward with Advanced CRISPR Sequencing by CD Genomics
-
Celebrating International Women’s Day and tackling inequality at Discovery Park
Discovery Park, Kent’s thriving life science community, is marking International Women’s Day by supporting women in business and tackling gender bias in healthcare.
Feb 27, 2024
-
Unraveling the Genomic Mysteries with CD Genomics’ RIP-Seq Services
-
UNIVERSITY OF EDINBURGH ACKNOWLEDGES PELAGO PATENT AND USE OF CETSA® PROCESS
Pelago Biosciences has announced that the University of Edinburgh has acknowledged its Cellular Thermal Shift Assay (CETSA®) patent and use thereof in selected works in drug discovery research.
Feb 26, 2024
-
Creative Enzymes Proudly Unveils Its Cutting-Edge Product, Recombinant Human Hyaluronidase PH20
-
Creative Enzymes Rolls out Customized Solutions in Enzyme, Probiotic and Extract Blends
-
Alfa Chemistry Unveils Its Range of Dietary Supplements: Fruit Juice Powder, Enzyme Powder, and Probiotics Product
In recent years, the demand for dietary supplements has been on the rise as more and more individuals seek to maintain a healthy lifestyle. Alfa Chemistry, a renowned chemical supplier, has unveiled its selection of dietary supplements, offering consumers a wide range of options to support their nutritional needs. With its new product line, including Fruit Juice Powder, Enzyme Powder, and Probiotics Product, Alfa Chemistry aims to provide natural and effective solutions for various health concerns.
Feb 26, 2024
-
Validated AI-Driven Target Identification and Biomarker Discovery with Insilico Medicine’s PandaOmics
PandaOmics is a cloud-based software platform from clinical stage artificial intelligence (AI)-driven drug discovery company Insilico Medicine that helps researchers identify therapeutic targets and discover new biomarkers in order to select the most promising targets to pursue based on all available data and pre-existing research. A new paper in the Journal of Chemical Information and Modeling provides definitive validation of this software platform.
Feb 25, 2024
-
AVIA’s Generative AI Strategic Collaborative Highlights Six-Month Milestones And Outlines Next Steps For Pioneering Initiative
-
From Simple Dressings to Smart Technology: The Rise of Smart Bandages in the Healthcare Landscape
Driven by the rise of chronic wounds, particularly those linked to diabetes, the healthcare industry sees a surge in innovative smart bandages. These advanced dressings offer faster healing, infection control, and real-time monitoring compared to traditional methods.
Feb 25, 2024
-
Backed by Leading Health Systems, Vale Health Launches at Vive 2024; Wellness Marketplace Platform Enables Self-Directed Access to Vetted Products
-
Creative Proteomics Expands Its Epigenetics Portfolio with Advanced Histone PTMs Analysis Service
-
Creative Proteomics Unveils Comprehensive Exosome Lipidomics Services
-
Alfa Chemistry Expands Selection of Click Chemistry Reagents: DBCO, BCN, and Tetrazines Included
-
Creative Proteomics Enhances Research Capabilities with Urine Untargeted Metabolomics